What does Dr. Van Geldre - Dr. Laga do?

Dr. Van Geldre - Dr. Laga is a specialist medical practice in Diest. Private Limited, started on 3 November 2004, 2 establishments.

What is the address of Dr. Van Geldre - Dr. Laga?

The registered office of Dr. Van Geldre - Dr. Laga is located at Molenweg 11, 3294 Diest.

Is Dr. Van Geldre - Dr. Laga still active?

Yes. According to the CBE (28 September 2026) Dr. Van Geldre - Dr. Laga is active, legal situation “Normale toestand”, started on 3 November 2004.

Is Dr. Van Geldre - Dr. Laga registered on Peppol?

Yes, Dr. Van Geldre - Dr. Laga is registered on the Peppol network with ID 0208:0870001611.

What is the enterprise number of Dr. Van Geldre - Dr. Laga?

The enterprise number of Dr. Van Geldre - Dr. Laga is BE0870001611.

When was Dr. Van Geldre - Dr. Laga founded?

Dr. Van Geldre - Dr. Laga was founded on 3 November 2004.

Who are the directors of Dr. Van Geldre - Dr. Laga?

According to the 2025 annual accounts, the directors of Dr. Van Geldre - Dr. Laga are: Luk Van Geldre, Katrien Laga.

Is Dr. Van Geldre - Dr. Laga a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 November 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Van Geldre - Dr. Laga make in 2025?

Dr. Van Geldre - Dr. Laga posted a profit after taxes of € 235,363 in financial year 2025.

What is the revenue of Dr. Van Geldre - Dr. Laga?

As a small company, Dr. Van Geldre - Dr. Laga is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 325,959.

Dr. Van Geldre - Dr. Laga (Private Limited) - Diest

Dossier Dr. Van Geldre - Dr. Laga, printed on 28 September 2026 from databakkes.be/en/0870001611/dr-van-geldre-dr-laga. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Van Geldre - Dr. Laga from Diest, company number BE0870001611, closed financial year 2025 with a result of € 235,363 after tax. For that financial year Dr. Van Geldre - Dr. Laga recorded a gross margin of € 325,959 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 250,282 to € 235,363. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 1.2 million

▼ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 235,363

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 296,868

▲ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 787,723 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 7,867

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 51,247

▲ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,262

▼ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 380,402 Gross margin 2022: € 380,402 First fiscal year in the series	€ 337,365 Gross margin 2023: € 337,365 ▼ 11% vs 2022 (€ 380,402) Unfavourable step	€ 331,843 Gross margin 2024: € 331,843 ▼ 2% vs 2023 (€ 337,365) Unfavourable step	€ 325,959 Gross margin 2025: € 325,959 ▼ 2% vs 2024 (€ 331,843) Unfavourable step	▼ 2%
Profit after taxes	€ 269,274 Profit after taxes 2022: € 269,274 First fiscal year in the series	€ 277,776 Profit after taxes 2023: € 277,776 ▲ 3% vs 2022 (€ 269,274) Favourable step	€ 250,282 Profit after taxes 2024: € 250,282 ▼ 10% vs 2023 (€ 277,776) Unfavourable step	€ 235,363 Profit after taxes 2025: € 235,363 ▼ 6% vs 2024 (€ 250,282) Unfavourable step	▼ 6%
Equity	€ 1,342,161 Equity 2022: € 1,342,161 First fiscal year in the series	€ 1,518,773 Equity 2023: € 1,518,773 ▲ 13% vs 2022 (€ 1,342,161) Favourable step	€ 1,769,055 Equity 2024: € 1,769,055 ▲ 16% vs 2023 (€ 1,518,773) Favourable step	€ 1,216,696 Equity 2025: € 1,216,696 ▼ 31% vs 2024 (€ 1,769,055) Unfavourable step	▼ 31%
Total debts	€ 78,837 Total debts 2022: € 78,837 First fiscal year in the series	€ 67,516 Total debts 2023: € 67,516 ▼ 14% vs 2022 (€ 78,837) Favourable step	€ 42,097 Total debts 2024: € 42,097 ▼ 38% vs 2023 (€ 67,516) Favourable step	€ 210,059 Total debts 2025: € 210,059 ▲ € 167,961 vs 2024 (€ 42,097) Unfavourable step	▲ € 167,961
Cash	€ 528,633 Cash 2022: € 528,633 First fiscal year in the series	€ 150,379 Cash 2023: € 150,379 ▼ 72% vs 2022 (€ 528,633) Unfavourable step	€ 188,778 Cash 2024: € 188,778 ▲ 26% vs 2023 (€ 150,379) Favourable step	€ 296,868 Cash 2025: € 296,868 ▲ 57% vs 2024 (€ 188,778) Favourable step	▲ 57%
Retained profit	€ 1,322,161 Retained profit 2022: € 1,322,161 First fiscal year in the series	€ 1,498,773 Retained profit 2023: € 1,498,773 ▲ 13% vs 2022 (€ 1,322,161) Favourable step	€ 1,749,055 Retained profit 2024: € 1,749,055 ▲ 17% vs 2023 (€ 1,498,773) Favourable step	€ 1,196,696 Retained profit 2025: € 1,196,696 ▼ 32% vs 2024 (€ 1,749,055) Unfavourable step	▼ 32%
Dividend	€ 139,958 Dividend 2022: € 139,958 First fiscal year in the series	€ 101,164 Dividend 2023: € 101,164 ▼ 28% vs 2022 (€ 139,958) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 101,164) Unchanged	€ 787,723 Dividend 2025: € 787,723 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,420,998 Balance sheet total 2022: € 1,420,998 First fiscal year in the series	€ 1,586,288 Balance sheet total 2023: € 1,586,288 ▲ 12% vs 2022 (€ 1,420,998) Unchanged	€ 1,811,152 Balance sheet total 2024: € 1,811,152 ▲ 14% vs 2023 (€ 1,586,288) Unchanged	€ 1,426,754 Balance sheet total 2025: € 1,426,754 ▼ 21% vs 2024 (€ 1,811,152) Unchanged	▼ 21%

Key figures of Dr. Van Geldre - Dr. Laga, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van Geldre - Dr. Laga?

What happened at Dr. Van Geldre - Dr. Laga in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 235,363 (▼ 6% vs 2024). Source: NBB ↗
Jan 15, 2025 New establishment in Oostende. KBO
Nov 3, 2004 New establishment in Diest. KBO
2004 Luk Van Geldre became a director. NBB
2004 Katrien Laga became a director. NBB
Nov 3, 2004 Start of the company according to the CBE. KBO

In short

From € 269,274 profit in 2022 to € 235,363 profit in 2025.

Paid € 475,950 in corporate taxes since 2022.

Best year ever: 2023, with € 277,776 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Van Geldre - Dr. Laga? We notify you, reason included.

Follow Dr. Van Geldre - Dr. Laga

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Luk Van Geldre Katrien Laga

Dr. Van Geldre - Dr. Laga

Behind Dr. Van Geldre - Dr. Laga are Luk Van Geldre and Katrien Laga.

See the full network in the app

Directors

According to the 2025 annual accounts

Luk Van Geldre

Director

since 2004

Katrien Laga

Director

since 2004

Establishments

Establishment units

Physical locations of this company

Registered office

Molenweg 11

3294 Diest

2.368.746.928

Victorialaan 1 box 4.03

8400 Oostende

Active since 15 January 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0870.001.611
VAT number: BE 0870.001.611
Registered office: Molenweg 11, 3294 Diest
Names & denominations: Dr. Van Geldre - Dr. Laga
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 November 2004
Peppol: Active · Active since 10 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗